| Initial Opitimism |
 |
 |
|
"Despite initial opitimism about the potential of combination antiretroviral therapy ultimately to eradicate the virus, few clinicians now expect to lengthen the life of their patients more than a few years before drug side effects and viral resistance undermine the benefits of therapy."
Rowland-Jones S, Pinheiro S, Kaul R New Insights into Host Factors in HIV-1 Pathogenesis Cell, February 2001 Vol.104, 473-476. Minireview PMID: 11239405 |